|
Sorted by: Date | Top Results
|
|
Author |
|
Date |
| |
| |
| 1. |
Petro-Canada Sinking Suncor in Quicksand 
Can Suncor control operating costs and get its debt
paid down towards the $10 billion range by the end
of 2010? http://industry.bnet.com/energy/10002949
/suncor-energy-gushes-over-oil-sands...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
Suncor Energy, Inc. (SU)
|
|
djphillips59 |
|
9-Feb-10 02:51 pm |
| |
| 2. |
HYPE AND HOPE OF DAVY JONES
Although the Davy Jones find could significantly add
to the company’s reserves, the structural complexity
of the site and the sophisticated imaging require
ments...
Business & Finance > Investments > Stocks (A to Z) > Stocks M >
McMoRan Exploration Co. (MMR)
|
|
djphillips59 |
|
3-Feb-10 10:18 am |
| |
| 3. |
BNET Pharma Exposes Efficacy Doubts
Controversy raging over actual efficacy of Ampyra:
http://industry.bnet.com/pharma/10006294/acorda-t
herapeutics-ms-drug-ampyra-could-stumble/
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
Acorda Therapeutics, Inc. (ACOR)
|
|
djphillips59 |
|
27-Jan-10 11:39 am |
| |
| 4. |
DEBUNKING ACORDA BUYOUT RUMORS
Forget about it! Debunking a rumored Acorda buyout:
http://industry.bnet.com/pharma/10006278/debunkin
g-the-acorda-therapeutics-merger-rumors/?tag=shell
;content
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
Acorda Therapeutics, Inc. (ACOR)
|
|
djphillips59 |
|
25-Jan-10 01:31 pm |
| |
| 5. |
PRILOSEC OTC HEADED FOR SOCIAL OBSCURITY?
Can P&G's Social Media activities save Prilosec
OTC from obscurity? http://industry.bnet.com/phar
ma/10006258/procter-gamble-wages-that-the-medium-a
nd-its-message-can-save-prilosec-otc/?tag=shell;co
ntent
Business & Finance > Investments > Stocks (A to Z) > Stocks P >
Procter & Gamble Co. (PG)
|
|
djphillips59 |
|
25-Jan-10 12:35 pm |
| |
| 6. |
Callaway Exports Technology
while competitors are responding to the global economic
slowdown by cutting back on expansion plans, Callaway
is forging ahead, establishing a...
Business & Finance > Investments > Stocks (A to Z) > Stocks C >
Callaway Golf Company (ELY)
|
|
djphillips59 |
|
22-Jan-10 01:30 pm |
| |
| 7. |
Ask the SLEEP EXPERTS: YES!
Dr. Neubauer comments on the potential merits of Silenor
as a drug treatment for insomnia: "None of us
are privy to the FDA communications with Somaxon,
so we can only speculate…. The low...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
Somaxon Pharmaceuticals, Inc.
|
|
djphillips59 |
|
22-Jan-10 10:23 am |
| |
| 8. |
Generic vs Brand Opioids
Primary care physicians and pain experts interviewed
by industry researcher Decision Resources affirmed
that an important unmet clinical need in the treatment
of chronic...
Business & Finance > Investments > Stocks (A to Z) > Stocks K >
King Pharmaceuticals (KG)
|
|
djphillips59 |
|
19-Jan-10 09:28 am |
| |
| 9. |
Tamiflu Gravy Train Derailed
Gilead receives a blended royalty on sales of Tamiflu
-- so Roche Holdings' mess it's making with
the drug can only hurt! http://industry.bnet.com/
pharma/10005827/efficacy-of-roches...
Business & Finance > Investments > Stocks (A to Z) > Stocks G >
Gilead Sciences, Inc. (GILD)
|
|
djphillips59 |
|
17-Dec-09 01:16 pm |
| |
| 10. |
Payer Push Back
Will insurers push back at Folotyn's price tag?
http://industry.bnet.com/pharma/10005799/how-much
-to-extend-life-allos-therapeutics-says-30000-per-
month/
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
Allos Therapeutics, Inc.
|
|
djphillips59 |
|
15-Dec-09 02:27 pm |
| |
| 11. |
LIVLO!
Can TriLipix, Crestor, or even Certriad compete against
Livlo? http://industry.bnet.com/pharma/10005711/a
bbott-labs-deal-with-teva-pharmaceuticals-is-phat-
news-for-lipid-lowering-franchise/
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
AstraZeneca PLC (AZN)
|
|
djphillips59 |
|
15-Dec-09 02:23 pm |
| |
| 12. |
Lump of Coal in GameStop&&39;s Stocking?
Could GameStop find coal in its Christmas stocking
this year? http://industry.bnet.com/retail/100055
61/wal-mart-looks-to-leave-gamestop-4-dead-this-ch
ristmas/
Business & Finance > Investments > Stocks (A to Z) > Stocks G >
GameStop Corp. (GME)
|
|
djphillips59 |
|
8-Dec-09 02:37 pm |
| |
| 13. |
Cost Cutting & Corn
Cost cutting will not be enough to shore up weak fundamentals.
Though refineries coming online in China and Brazil
are expected to serve domestic...
Business & Finance > Investments > Stocks (A to Z) > Stocks V >
Valero Energy Corp. (VLO)
|
|
djphillips59 |
|
7-Dec-09 05:18 pm |
| |
| 14. |
Racing to Oral MS Finish Line
Can fingolimod cross the finish line before German
drug maker Merck KgaA’s cladribine tablet and be first
oral MS treatment to market? http://industry.bnet
.com/pharma/10005592/can-novartis-win-race-to-laun
ch-first-ms-oral-drug/
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Novartis AG (NVS)
|
|
djphillips59 |
|
7-Dec-09 04:53 pm |
| |
| 15. |
Insight Behind Novartis - Incyte Deal
Insight behind deal: http://industry.bnet.com/phar
ma/10005537/can-novartis-jak-up-incytes-profitabil
ity/
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Novartis AG (NVS)
|
|
djphillips59 |
|
2-Dec-09 09:00 am |
| |
| 16. |
Novartis-Incyte Analysis
With an accumulated deficit of $1.3 billion sitting
on its balance sheet, Incyte knows first hand the
financial risks that coincide with navigating a small
molecule compound from...
Business & Finance > Investments > Stocks (A to Z) > Stocks I >
Incyte Corporation
|
|
djphillips59 |
|
2-Dec-09 08:57 am |
| |
| 17. |
Implications of Incyte Deal
Company looks for new meds to replace generic roadbloack
ahead: http://industry.bnet.com/pharma/10005537/c
an-novartis-jak-up-incytes-profitability/
Business & Finance > Investments > Stocks (A to Z) > Stocks P >
Pfizer Inc. (PFE)
|
|
djphillips59 |
|
1-Dec-09 09:31 pm |
| |
| 18. |
Generic Challenges to BP Franchise
Novartis AG loses patent protection for its $4.4 billion
blood pressure medicine Diovan (valsartan) in the
major countries of the European Union in 2011 and
the following September here in the U.S. Expect g
eneric...
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Novartis AG (NVS)
|
|
djphillips59 |
|
27-Nov-09 11:56 am |
| |
| 19. |
Rig Recovery Overblown
Talk of a significant recovery in rig demand might
be premature, however, given the current supply overhang
in the natural gas market. http://industry.bnet.c
om/energy/10002556/inconvenient-truth-recovery-but
-no-recovery-at-driller...
Business & Finance > Investments > Stocks (A to Z) > Stocks P >
Patterson-UTI Energy, Inc (PTEN)
|
|
djphillips59 |
|
27-Nov-09 11:51 am |
| |
| 20. |
Will Dermatologists Embrace Stelara?
Commercial success of Stelara could hinge on acceptance
by dermatologists: http://industry.bnet.com/pharma/10005423/why-jjs-stelara-launch-should-target-dermatologists-first/
Agree or...
Business & Finance > Investments > Stocks (A to Z) > Stocks J >
Johnson & Johnson (JNJ)
|
|
djphillips59 |
|
23-Nov-09 11:48 am |
| |
